WORK Cost Of Revenue from 2010 to 2024

WOK Stock   5.46  0.75  15.92%   
WORK Medical Cost Of Revenue yearly trend continues to be quite stable with very little volatility. The value of Cost Of Revenue is projected to decrease to about 8.1 M. From the period between 2010 and 2024, WORK Medical, Cost Of Revenue regression line of its data series had standard deviation of  14,302,764 and standard deviation of  14,302,764. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
8.5 M
Current Value
8.1 M
Quarterly Volatility
14.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check WORK Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WORK Medical's main balance sheet or income statement drivers, such as Tax Provision of 40.2 K, Interest Expense of 359.7 K or Selling General Administrative of 3.1 M, as well as many indicators such as . WORK financial statements analysis is a perfect complement when working with WORK Medical Valuation or Volatility modules.
  
Check out the analysis of WORK Medical Correlation against competitors.

Latest WORK Medical's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of WORK Medical Technology over the last few years. Cost of Revenue is found on WORK Medical Technology income statement and represents the costs associated with goods and services WORK Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is WORK Medical's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in WORK Medical's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

WORK Cost Of Revenue Regression Statistics

Arithmetic Mean33,018,091
Geometric Mean28,241,403
Coefficient Of Variation43.32
Mean Deviation12,109,279
Median41,679,440
Standard Deviation14,302,764
Sample Variance204.6T
Range33.6M
R-Value(0.80)
Mean Square Error80T
R-Squared0.64
Significance0.0004
Slope(2,552,672)
Total Sum of Squares2864T

WORK Cost Of Revenue History

20248.1 M
20238.5 M
20229.4 M
202115.3 M
202037.2 M

About WORK Medical Financial Statements

WORK Medical investors utilize fundamental indicators, such as Cost Of Revenue, to predict how WORK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue8.5 M8.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether WORK Medical Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if WORK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Work Medical Technology Stock. Highlighted below are key reports to facilitate an investment decision about Work Medical Technology Stock:
Check out the analysis of WORK Medical Correlation against competitors.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WORK Medical. If investors know WORK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about WORK Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of WORK Medical Technology is measured differently than its book value, which is the value of WORK that is recorded on the company's balance sheet. Investors also form their own opinion of WORK Medical's value that differs from its market value or its book value, called intrinsic value, which is WORK Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WORK Medical's market value can be influenced by many factors that don't directly affect WORK Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WORK Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WORK Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WORK Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.